Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | BMC Medicine

Fig. 5

From: Major milestones in translational oncology

Fig. 5

Helena Earl. Helena Earl is an academic clinician in Medical Oncology and currently Professor of Clinical Cancer Medicine at the University of Cambridge, Department of Oncology and a Principal Investigator of the NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre. She is co-lead for the Breast Cancer Programme at the Cancer Research UK Cambridge Cancer Centre and significantly contributes to the translational endeavor in precision medicine and the development of personalized treatment pathways in breast cancer. In Cambridge, she is the cancer lead in the collaborative workstream for novel adaptive trial designs

Back to article page